DK0966277T3 - Anvendelse af R-NSAID'er til forebyggelse af Alzheimer's sygdom - Google Patents

Anvendelse af R-NSAID'er til forebyggelse af Alzheimer's sygdom

Info

Publication number
DK0966277T3
DK0966277T3 DK98908904T DK98908904T DK0966277T3 DK 0966277 T3 DK0966277 T3 DK 0966277T3 DK 98908904 T DK98908904 T DK 98908904T DK 98908904 T DK98908904 T DK 98908904T DK 0966277 T3 DK0966277 T3 DK 0966277T3
Authority
DK
Denmark
Prior art keywords
disease
nsaids
prevent alzheimer
alzheimer
nsaid
Prior art date
Application number
DK98908904T
Other languages
Danish (da)
English (en)
Inventor
William J Wechter
John D Mccracken
Original Assignee
Univ Loma Linda Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/814,490 external-priority patent/US6160018A/en
Application filed by Univ Loma Linda Med filed Critical Univ Loma Linda Med
Application granted granted Critical
Publication of DK0966277T3 publication Critical patent/DK0966277T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK98908904T 1997-03-10 1998-03-04 Anvendelse af R-NSAID'er til forebyggelse af Alzheimer's sygdom DK0966277T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/814,490 US6160018A (en) 1995-03-13 1997-03-10 Prophylactic composition and method for alzheimer's Disease

Publications (1)

Publication Number Publication Date
DK0966277T3 true DK0966277T3 (da) 2006-03-27

Family

ID=25215202

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98908904T DK0966277T3 (da) 1997-03-10 1998-03-04 Anvendelse af R-NSAID'er til forebyggelse af Alzheimer's sygdom

Country Status (9)

Country Link
EP (2) EP0966277B1 (fr)
JP (1) JP2001514655A (fr)
AT (2) ATE311865T1 (fr)
AU (1) AU6682298A (fr)
CA (1) CA2283255C (fr)
DE (2) DE69841267D1 (fr)
DK (1) DK0966277T3 (fr)
ES (1) ES2253810T3 (fr)
WO (1) WO1998040061A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2163986B1 (es) * 1999-07-13 2003-02-16 Menarini Lab Acidos-alfa-arilpropionicos y arilaceticos como inhibidores de la ciclooxigenasa-ii.
AU5702201A (en) * 2000-04-13 2001-10-30 Mayo Foundation Abeta<sub>42</sub> lowering agents
JP2006502188A (ja) * 2002-09-17 2006-01-19 ニューヨーク ユニバーシティ 年齢関連記憶欠陥（ａａｍｉ）、中程度認識欠陥（ｍｃｉ）、および痴呆を細胞周期インヒビターで処置する方法
US7074826B2 (en) * 2002-10-07 2006-07-11 Encore Pharmaceuticals, Inc. R-NSAID esters and their use
US7521481B2 (en) 2003-02-27 2009-04-21 Mclaurin Joanne Methods of preventing, treating and diagnosing disorders of protein aggregation
AU2004311577A1 (en) * 2003-07-11 2005-07-21 Myriad Genetics, Inc. Pharmaceutical methods, dosing regimes and dosage forms for the treatment of Alzheimer's disease
US8110681B2 (en) * 2006-03-17 2012-02-07 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Compounds for the treatment of spinal muscular atrophy and other uses
US20090238763A1 (en) 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
WO2008034244A1 (fr) * 2006-09-21 2008-03-27 Waratah Pharmaceuticals Inc. Combinaison d'un cyclohexanehexol et d'un ains pour le traitement des maladies neurodegeneratives
KR20150058566A (ko) 2007-06-04 2015-05-28 테크필즈 인크 매우 높은 피부 및 막 침투율을 가지는 ｎｓａｉａ 약물전구체 및 이들의 새로운 의약적 용도
KR20210123406A (ko) 2008-12-04 2021-10-13 충시 위 고투과력을 가진 조성물 및 이의 적용
JP6445967B2 (ja) 2012-05-16 2018-12-26 テックフィールズ ファーマ カンパニー リミテッド 肺疾患の治療のための高浸透性プロドラッグ組成物およびその薬学的組成物
JP6228302B2 (ja) 2013-07-11 2017-11-08 ユニバーシティー オブ ノース テキサス ヘルス サイエンス センター アット フォートワースＵｎｉｖｅｒｓｉｔｙ Ｏｆ Ｎｏｒｔｈ Ｔｅｘａｓ Ｈｅａｌｔｈ Ｓｃｉｅｎｃｅ Ｃｅｎｔｅｒ Ａｔ Ｆｏｒｔ Ｗｏｒｔｈ プライマリーケアセッティングにおいて神経学的疾患を検出するための血液に基づくスクリーニング
JP6364488B2 (ja) 2013-11-26 2018-07-25 ユニバーシティー オブ ノース テキサス ヘルス サイエンス センター アット フォートワースＵｎｉｖｅｒｓｉｔｙ Ｏｆ Ｎｏｒｔｈ Ｔｅｘａｓ Ｈｅａｌｔｈ Ｓｃｉｅｎｃｅ Ｃｅｎｔｅｒ Ａｔ Ｆｏｒｔ Ｗｏｒｔｈ 認知欠損を治療するための個別化医療的手法
AU2019209792A1 (en) * 2018-01-18 2020-08-13 University Of North Texas Health Science Center At Fort Worth Companion diagnostic for NSAIDs and donepezil for treating specific subpopulations of patients suffering from alzheimer's disease

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4028906A1 (de) * 1990-09-12 1992-03-19 Paz Arzneimittelentwicklung Arzneimittel sowie deren herstellung und deren verwendung bei der bekaempfung von schmerzen und/oder entzuendungen und/oder fieber an tieren und menschen
US5192753A (en) * 1991-04-23 1993-03-09 Mcgeer Patrick L Anti-rheumatoid arthritic drugs in the treatment of dementia
FR2687915B1 (fr) * 1992-02-28 1995-05-05 Rhone Poulenc Rorer Sa Composition pharmaceutique utilisable comme analgesique contenant l'acide (benzoyl-3 phenyl)-2 propionique-(r).
US5331000A (en) * 1992-03-09 1994-07-19 Sepracor Inc. Antipyretic and analgesic methods and compositions containing optically pure R(-) ketoprofen
US5382591A (en) * 1992-12-17 1995-01-17 Sepracor Inc. Antipyretic and analgesic methods using optically pure R-ketorolac
US6160018A (en) * 1995-03-13 2000-12-12 Loma Linda University Medical Center Prophylactic composition and method for alzheimer's Disease
US5955504A (en) * 1995-03-13 1999-09-21 Loma Linda University Medical Center Colorectal chemoprotective composition and method of preventing colorectal cancer
WO1997048391A2 (fr) * 1996-06-21 1997-12-24 Advanced Research And Technology Institute Methodes et compositions a base de r-ibuprofene

Also Published As

Publication number Publication date
DE69832695D1 (de) 2006-01-12
DE69832695T2 (de) 2006-09-14
WO1998040061A1 (fr) 1998-09-17
DE69841267D1 (de) 2009-12-10
EP1642575A1 (fr) 2006-04-05
ATE446748T1 (de) 2009-11-15
JP2001514655A (ja) 2001-09-11
CA2283255C (fr) 2007-01-02
EP0966277B1 (fr) 2005-12-07
EP0966277A1 (fr) 1999-12-29
CA2283255A1 (fr) 1998-09-17
ES2253810T3 (es) 2006-06-01
EP1642575B1 (fr) 2009-10-28
ATE311865T1 (de) 2005-12-15
AU6682298A (en) 1998-09-29

Similar Documents

Publication Publication Date Title
DK0966277T3 (da) Anvendelse af R-NSAID&#39;er til forebyggelse af Alzheimer&#39;s sygdom
TR200000129T2 (tr) Yepyeni spiroazabisiklik heterosiklik bileşikler.
NZ334124A (en) Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer&#39;s disease
ID24487A (id) Senyawa-senyawa benzosikloheptatiofen
BR0002073A (pt) Processo para a preparação de um composto quiral
DK0979079T3 (da) Anvendelse af tetrahydropyridinderivater til fremstilling af lægemidler til behandling af sygdomme, der medförer en demyelinisering
IT1302243B1 (it) Sintesi dell&#39;1,1,1,3,3-pentafluoropropano.
DE69808440D1 (de) Verwendung von (+)mefloquine zur behandlung von malaria
DE60128100D1 (de) Analgetisches arzneimittel
FR2684543B1 (fr) Ligament artificiel, notamment pour la cheville.
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
DZ1576A1 (fr) Compostions therapeutiques à base de dérives de 1,2-dithiole-3-thione.
DK0424156T3 (da) Behandling af hepatobiliær sygdom med 15-ketoprostaglandinforbindelser
WO2000010554A3 (fr) Procedes et compositions employant le vigabatrin s(+) optiquement pur
DK0896822T3 (da) 4-aminopyrrol (3,2-d) pyrimidiner som neuropeptide Y receptorantagonister
WO2002099422A3 (fr) Personnalisation de therapie avec des agents de la maladie d&#39;alzheimer
DK0454429T3 (da) Anvendelse af 15-dehydroxy-16-oxoprostaglandinderivater til behandling af allergiske sygdomme
SE9701438D0 (sv) A new process
IT1296613B1 (it) Farmaco per la cura dell&#39;ircismo contenente un adrenocorticosteroide.
EE200200215A (et) 2-amino-3,4-dihüdrokinasoliinide kasutamine ravimi valmistamiseks, mis on ette nähtud isheemilistest seisunditest tingitud haiguste raviks või ennetamiseks
SE9501773D0 (sv) New use
FR2680953B1 (fr) Semelle deodorante, antibacteries, hydrothermique jetable.
SE9304236D0 (sv) New use
NO970190D0 (no) Preparat til behandling av Parkinsons sykdom
IT8822273A0 (it) Procedimento per la preparazione di 1,2-difluoro-1,1,2,2tetacloroetano sostanzialmente privo dell&#39;isomero 1,1-difluoro 1,2,2,2-tetracloroetano.